Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Central cloudy dystrophy of François is a very rare form of stromal corneal dystrophy characterized by polygonal or rounded stromal opacities surrounded by clear tissue, and generally no effect on vision.
Features include: Clouding of the cornea (corneal dystrophy) and Central corneal dystrophy.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 2 | Clouding of the cornea (corneal dystrophy), Central corneal dystrophy |
Biomarker and diagnostic research for central cloudy dystrophy of François has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for central cloudy dystrophy of François.
17 publications have been identified in PubMed for central cloudy dystrophy of François. Research spans Review / Meta-Analysis (20%), Case Report / Case Series (20%), and Clinical Trial Publication (20%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 3 | 20% |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 5:51 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Patient case studies
3 |
20% |
Clinical study results | 3 | 20% |
Laboratory research | 3 | 20% |
Testing and diagnosis research | 1 | 7% |
Disease patterns and progression | 1 | 7% |
New treatment approaches | 1 | 7% |
Ekincikli AM (2026). [PMID: 41872717](https://pubmed.ncbi.nlm.nih.gov/41872717/). *Eye Contact Lens*. [Case Report / Case Series]
Zhao H (2026). [PMID: 42070230](https://pubmed.ncbi.nlm.nih.gov/42070230/). *Adv Sci (Weinh)*. [Gene Therapy / Novel Therapeutics]
Paoletti T (2026). [PMID: 41949920](https://pubmed.ncbi.nlm.nih.gov/41949920/). *Cornea*. [Clinical Trial Publication]
Yeh TC (2026). [PMID: 42033570](https://pubmed.ncbi.nlm.nih.gov/42033570/). *Doc Ophthalmol*. [Basic Science / Preclinical]
Zhang W (2026). [PMID: 41896991](https://pubmed.ncbi.nlm.nih.gov/41896991/). *Biol Sex Differ*. [Basic Science / Preclinical]
Touirssa O (2025). [PMID: 40874967](https://pubmed.ncbi.nlm.nih.gov/40874967/). *J Epidemiol Glob Health*. [Epidemiology / Natural History]
Cuadrado AV (2025). [PMID: 40325211](https://pubmed.ncbi.nlm.nih.gov/40325211/). *Graefes Arch Clin Exp Ophthalmol*. [Clinical Trial Publication]
Alayed B (2025). [PMID: 42180433](https://pubmed.ncbi.nlm.nih.gov/42180433/). *Mol Vis*. [Basic Science / Preclinical]
Adachi R (2025). [PMID: 39618086](https://pubmed.ncbi.nlm.nih.gov/39618086/). *Ophthalmic Genet*. [Case Report / Case Series]
Ramirez-Miranda A (2025). [PMID: 40501480](https://pubmed.ncbi.nlm.nih.gov/40501480/). *Clin Ophthalmol*. [Review / Meta-Analysis]